Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A Phase 3, Randomized, Open-label Study of NKTR-214 Combined with Nivolumab Versus Nivolumab in Participants with Previously Untreated Unresectable or Metastatic Melanoma.
Moore, Maggie
(Primary Chief Investigator (PCI))
Hawkins, Cheryl-Ann
(Project Manager)
Undergraduate Teaching Alfred Hospital
Health Systems Services & Policy
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
30/08/19
→
31/12/23
View all
View less
Keywords
Medical oncology
Melanoma
Clinical trial